Blog
Snapchat Is Quietly Building an Impressive Video Business
Imagine a company that reaches a people other companies struggle to engage, and which enjoys an expanding demographic reach, a fast-growing video presence, and an app that users open 30 times a day
Why Realty Income Is a Dividend Investor's Dream
How can an income investor not like a business that calls itself "The Monthly Dividend Company"? Realty Income (NYSE: O) has more than earned its way onto the list of Dividend Aristocrats, companies
Citigroup: Value or Value Trap?
Citigroup (NYSE: C) has seen its stock price drop about 36% this year, to around $51 per share at Monday's close. That's quite a sell-off -- but does that make Citigroup a good value?
5 High-Growth Tech Stocks Robinhood Investors Are Buying Hand Over Fist
The Robinhood app has certainly made a name for itself in 2020. Despite several previous missteps, the investment trading platform has become a hit with millennials and younger investors
Should You Invest in the S&P 500 and Apple at All-Time Highs?
The rebound in the stock market in the months since the COVID-19 pandemic started has been incredible. The S&P 500 is now 53% above its March lows and just hit a fresh all-time high as I sat down to
If You Invested $10,000 in AstraZeneca During the Last Recession, This Is How Much You Would Have Today
This year has been full of stomach-turning highs and lows for the stock market. Investing amid volatility isn't for the faint of heart, but those able to deal with the ups and downs know that this
Is ADMA Biologics a Good Coronavirus Stock to Buy Now?
The number of authorized coronavirus treatment options increased by one over the weekend, and the market's already pushing up shares of companies that could see a related revenue bump. The Food and
Robinhood Investors Are Scooping Up Fractional Shares of These 5 Stocks
Robinhood is changing the way people invest, largely by targeting younger and beginning investors and making it really easy to trade stocks.
One way the online trading platform has done that is to
Here's How Much Stock Key Novavax Insiders Just Sold
Novavax (NASDAQ: NVAX) ranks among the hottest stocks on the market so far in 2020. Its shares skyrocketed nearly 4,400% before pulling back over the last two weeks.
Some investors have decided to
3 Robinhood Stocks You Can Hold Until Retirement
Robinhood, the popular no-commission trading app, has become controversial in recent months.
Critics have accused traders on the app of inflating a volatile market into bubblicious territory, and
Is VBI Vaccines Stock a Buy?
Coming into 2020, you might have expected the only really big story for VBI Vaccines (NASDAQ: VBIV) would be Sci-B-Vac, its hepatitis B vaccine. While the company has certainly achieved progress in
3 Tech Stocks Billionaires Bought Hand Over Fist in Q2
With all that's going on in the country right now, between the coronavirus disease 2019 (COVID-19) pandemic and the upcoming local, state, and national elections in November, you might have missed
3 Things You Need to Know About Working and Collecting Social Security at the Same Time
Social Security is a complex program with lots of intricate rules. The more you learn about it, the easier it'll be to make the most of your benefits. Social Security has specific rules when it
What You Need to Know About the "Breakthrough" Coronavirus Therapy Heralded by President Trump
White House press secretary Kayleigh McEnany tweeted on Saturday that President Trump would hold a news conference on Sunday evening related to a "major therapeutic breakthrough" in treating
Apple's Stock Split: How Will It Actually Work?
Apple (NASDAQ: AAPL) recently announced that it will do a 4-for-1 stock split. The move marks the first time in six years that the tech giant has split its shares. It set off another round of
Is Progressive a Great Dividend Stock?
As an auto insurance specialist, Progressive (NYSE: PGR) hasn't been hit as hard by the COVID-19 pandemic as others in the industry, particularly health and life insurers. Its year-to-date returns
3 of the Fastest-Growing Stocks Robinhood Investors Are Buying
This has been a year of many records. We've seen the benchmark S&P 500 nosedive into bear market territory faster than ever before, and saw the broad-based index erase the entirety of its
Fanhua Inc. (FANH) Q2 2020 Earnings Call Transcript
Image source: The Motley Fool.
Fanhua Inc. (NASDAQ: FANH)Q2 2020 Earnings CallAug 25, 2020, 9:00 p.m. ET
Operator
Source Fool.com
Salesforce to Join Dow Jones Industrial Average
Cloud-based software provider salesforce.com (NYSE: CRM) has joined the ranks of what many consider to be the most influential and exclusive stock index of them all: the Dow Jones Industrial Average
Alphabet's Google Investing $100 Million in Telehealth Company Amwell During IPO
Alphabet's (NASDAQ: GOOG)(NASDAQ: GOOGL) Google Cloud unit is about to buy into the fast-growing telehealth segment with a $100 million investment into Class C shares of Amwell, a company that has
Report: Apple to Reopen a "Small Number" of Stores Closed by the Pandemic
Is your local Apple (NASDAQ: AAPL) store open or closed? Many of the company's retail outlets closed and then reopened -- only to close once more after COVID-19 cases surged in certain areas of the
Viomi Technology Co Ltd (VIOT) Q2 2020 Earnings Call Transcript
Image source: The Motley Fool.
Viomi Technology Co Ltd (NASDAQ: VIOT)Q2 2020 Earnings CallAug 24, 2020, 8:00 a.m. ET
Operator
Source Fool.com
Novavax Starts Phase 2 Coronavirus Vaccine Clinical Trial
Novavax (NASDAQ: NVAX) is behind the leaders in the race to develop a coronavirus vaccine to prevent COVID-19, but the biotech continues to trot along. On the heels of positive phase 1 data earlier
Teva Pharmaceuticals Unit Actavis Generics Wins FDA Approval for Lung Cancer Drug Pemetrexed
Teva Pharmaceuticals (NYSE: TEVA) has a new treatment it can market. The company's Actavis Generics unit has been granted Food and Drug Administration (FDA) approval for its Pemetrexed chemotherapy
Why GrowGeneration Got Hammered on Monday
Considered a marijuana stock, gardening supply specialist GrowGeneration (NASDAQ: GRWG) wilted badly on Monday. Its shares fell by over 17% on Monday after the company responded to allegations from


